Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source

Journal of Cell Biology

Volumn 144, Issue 6, 1999, Pages 1113-1121

  Beauchamp, Jonathan R ^a   Morgan, Jennifer E ^a   Pagel, Charles N ^a   Partridge, Terence A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cell heterogeneity; mdx mouse; Myoblast transplantation; Skeletal muscle; Stem cells

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL FATE; CELL FUNCTION; CELL HETEROGENEITY; CELL RENEWAL; CELL TRANSPLANTATION; CONTROLLED STUDY; MALE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELL TRANSPLANTATION; CLONE CELLS; FEMALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 0033594119     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.6.1113     Document Type: Article

References (46)

1. Baroffio, A., M.-L. Bochaton-Piallet, G. Gabbiani, and C.R. Bader. 1995. Heterogeneity in the progeny of single human muscle satellite cells. Differentiation. 59:259-268.
2. Baroffio, A., M. Hamann, L. Bernheim, M.-L. Bochaton-Piallat, G. Gabbiani, and C.R. Bader. 1996. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation. 60:47-57.
3. Barr, E., and J.M. Leiden. 1991. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 254:1507-1509.
4. Beauchamp, J.R., C.N. Pagel, and T.A. Partridge. 1997. A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation. 63:1794-1797.
5. Blau, H.M., and M.L. Springer. 1995. Muscle-mediated gene therapy. N. Engl. J. Med. 333:1554-1556.
6. Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8:144-149.
7. Cossu, G., M.G. Cusella-De Angelis, L. De Angelis, A. Mezzogiorno, P. Murphy, M. Coletta, E. Vivarelli, M. Bouché, and M. Molinaro. 1992. Multiple myogenic cell precursors and their possible role in muscle histogenesis. In Neuromuscular Development and Disease. A.M. Kelly and H.M. Blau, editors. Raven Press, Ltd., New York. 183-194.
8. Dhawan, J., L.C. Pan, G.K. Pavlath, M.A Travis, A.M. Lanctot, and H.M. Blau. 1991. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 254:1509-1512.
9. DiMario, J.X., and F.E. Stockdale. 1995. Differences in the developmental fate of cultured and noncultured myoblasts when transplanted into embryonic limbs. Exp. Cell Res. 216:431-442.
10. Dominov, J.A., J.J. Dunn, and J.B. Miller. 1998. Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J. Cell Biol. 142:537-544.
11. Drew, R.M., and R.B. Painter. 1962. Further studies on the clonal growth of HeLa S3 cells treated with tritiated thymidine. Radiat. Res. 16:303-311.
12. Fan, Y., M. Maley, M. Beilharz, and M. Grounds. 1996. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve. 19:853-860.
13. Ferrari, G., G. Cusella-De Angelis, M. Coletta, E. Paolucci, A. Stronaiuolo, G. Cossu, and F. Mavilio. 1998. Muscle regeneration by bone marrow-derived myogenic precursors. Science. 279:1528-1530.
14. Grounds, M., T.A. Partridge, and J.C. Sloper. 1980. The contribution of exogenous cells to regenerating skeletal muscle: an isoenzyme study of muscle allografts in mice. J. Pathol. 132:325-341.
15. Guérette, B., I. Asselin, D. Skuk, M. Entman, and J.P. Tremblay. 1997. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant. 6:101-107.
16. Gussoni, E., G.K. Pavlath, A.M. Lanctot, K.R. Sharma, R.G. Miller, L. Steinman, and H.M. Blau. 1992. Normal dystrophin transcripts in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 356:435-438.
17. Gussoni, E., H.M. Blau, and L.M. Kunkel. 1997. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nature Med. 3:970-977.
18. Hamamori, Y., B. Samal, J. Tian, and L. Kedes. 1995. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95:1808-1813.
19. Huard, J., G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1994. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:949-958.
20. Karpati, G., D. Ajdukovic, D. Arnold, R.B. Gledhill, R. Guttmann, P. Holland, P.A. Koch, E. Shoubridge, D. Spence, M. Vanasse, et al. 1993. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34:8-17.
21. Kaufman, S.J., and R.F. Foster. 1988. Replicating myoblasts express a muscle-specific phenotype. Proc. Natl. Acad. Sci. USA. 85:9606-9610.
22. Law, P.K., T.G. Goodwin, Q. Fang, M.B. Deering, V. Duggirala, C. Larkin, J.A. Florendo, D.S. Kirby, H.J. Li, M. Chen, et al. 1993. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant. 2:485-505.
23. Mendell, J.R., J.T. Kissel, A.A. Amato, W. King, L. Signore, T.W. Prior, Z. Sahenk, S. Benson, P.E. McAndrew, R. Rice, et al. 1995. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:832-838.
24. Miller, R.G., K.R. Sharma, G.K. Pavlath, E. Gussoni, M. Mynhier, P. Yu, B.S. Lanctot, C.M. Greco, L. Steinman, and H.M. Blau. 1997. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve. 20:469-478.
25. Morandi, L., P. Bernasconi, M. Gebbia, M. Mora, F. Crosti, R. Mantegazza, and F. Cornelio. 1995. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromuscul. Disord. 5:291-295.
26. Morgan, J.E., E.P. Hoffman, and T.A. Partridge. 1990. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 111:2437-2449.
27. Morgan, J.E., C.N. Pagel, T. Sherratt, and T.A. Partridge. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J. Neurol. Sci. 115:191-200.
28. Morgan, J.E., J.R. Beauchamp, C.N. Pagel, M. Peckham, P. Ataliotis, P.S. Jat, M.D. Noble, K. Farmer, and T.A. Partridge. 1994. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162:486-498.
29. Nishioka, Y. 1988. Application of Y chromosomal repetitive sequences to sexing mouse embryos. Teratology. 38:181-185.
30. Partridge, T.A., and K.E. Davies. 1995. Myoblast-based gene therapies. Br. Med. Bull. 51:123-137.
31. Partridge, T.A., J.E. Morgan, G.R. Coulton, E.P. Hoffman, and L.M. Kunkel. 1989. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 337:176-179.
32. Pastoret, C., and A. Sebille. 1995. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve. 18:1147-1154.
33. Pastoret, C., and T.A. Partridge. 1998. Muscle regeneration. In Cellular and Molecular Basis of Regeneration: From Invertebrates to Humans. P. Ferretti and J. Géraudie, editors. John Wiley and Sons Ltd., Chichester, UK. 309-333.
34. Ponchio, L., E. Conneally, and C. Eaves. 1995. Quantitation of the quiescent fraction of long-term culture-initialing cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood. 86:3314-3321.
35. Qu, Z., L. Balir, J.C.T. van Deutekom, P.D. Robbins, R. Pruchnic, and J. Huard. 1998. Development of approaches to improve cell survival in myoblast transplantation therapy. J. Cell Biol. 142:1257-1267.
36. Rantanen, J., T. Hurme, R. Lukka, J. Heino, and H. Kalimo. 1995. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab. Invest. 72:341-347.
37. Roy, R., J.-P. Tremblay, J. Huard, C. Richards, F. Malouin, and J.-P. Bouchard. 1993. Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. Transplant. Proc. 25:995-997.
38. Schultz, E. 1996. Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175:84-94.
39. Schultz, E., and D.L. Jaryszak. 1985. Effects of skeletal muscle regeneration on the proliferation potential of satellite cells. Mech. Ageing Dev. 30:63-72.
40. Smith, T.H., N.E. Block, S.J. Rhodes, S.F. Konieczny, and J.B. Miller. 1993. A unique pattern of expression of the four muscle regulatory factor proteins distinguishes somitic from embryonic, fetal and newborn mouse myogenic cells. Development. 117:1125-1133.
41. Tremblay, J.P., and B. Guerette. 1997. Myoblast transplantation: a brief review of the problems and some solutions. Basic Appl. Myology. 7:221-230.
42. Tremblay, J.P., J.P. Bouchard, F. Malouin, D. Théau, F. Cottrell, H. Collin, A. Rouche, S. Gilgenkrantz, N. Abbadi, M. Tremblay, et al. 1993a. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul. Disord. 3:583-592.
43. Tremblay, J.P., F. Malouin, R. Roy, J. Huard, J.P. Bouchard, A. Satoh, and C.L. Richards. 1993b. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:99-112.
44. Vilquin, J.-T., I. Kinoshita, B. Roy, M. Goulet, E. Engvall, F. Tomé, M. Fardeau, and J.P. Tremblay. 1996. Partial laminin α2 chain restoration in α2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J. Cell Biol. 133:185-197.
45. Yao, S.N., K.J. Smith, and K. Kurachi. 1994. Primary myoblast-mediated gene transfer: persistent expression of human factor-IX in mice. Gene Ther. 1:99-107.
46. Yoshida, N., S. Yoshida, K. Koishi, K. Masuda, and Y. Nabeshima. 1998. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates "reserve cells." J. Cell Sci. 111:769-779.